FdaApplication
ANDA 203611
Identifiers
- fda_app_no: ANDA203611
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC |
| application_type | ANDA |
| approval_date | 2026-06-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN | GABAPENTIN | 300MG | TABLET;ORAL |
| GABAPENTIN | GABAPENTIN | 600MG | TABLET;ORAL |
2 products